Patient characteristics
Characteristic . | Values . |
|---|---|
| Median age, y (range) | 44 (20-63) |
| Bulky mass more than 10 cm, no. patients | 34 |
| Stage, no. patients | |
| I | 1 |
| II | 4 |
| III | 4 |
| IV | 46 |
| Extranodal sites, no. patients | |
| Pleura | 21 |
| Bone marrow | 16 |
| Liver | 15 |
| Pericardium | 10 |
| Bone | 8 |
| Lung | 8 |
| Kidney | 4 |
| Gastrointestinal tract | 3 |
| Muscle | 3 |
| Ascites | 3 |
| Skin | 1 |
| 2 or more extranodal sites, no. patients | 36 |
| Elevated serum LDH level, no. patients | 47 |
| ECOG performance status, no. patients | |
| 1 | 12 |
| 2 | 29 |
| 3 | 13 |
| 4 | 1 |
| AAIPI risk factors, no. patients | |
| 2 | 20 |
| 3 | 35 |
| Histology, no. patients | |
| DLBCL | 51 |
| Burkitt lymphoma | 1 |
| Post-MTX DLBCL | 1 |
| Follicular grade 3 lymphoma | 1 |
| γδ Hepatosplenic T-cell lymphoma | 1 |
Characteristic . | Values . |
|---|---|
| Median age, y (range) | 44 (20-63) |
| Bulky mass more than 10 cm, no. patients | 34 |
| Stage, no. patients | |
| I | 1 |
| II | 4 |
| III | 4 |
| IV | 46 |
| Extranodal sites, no. patients | |
| Pleura | 21 |
| Bone marrow | 16 |
| Liver | 15 |
| Pericardium | 10 |
| Bone | 8 |
| Lung | 8 |
| Kidney | 4 |
| Gastrointestinal tract | 3 |
| Muscle | 3 |
| Ascites | 3 |
| Skin | 1 |
| 2 or more extranodal sites, no. patients | 36 |
| Elevated serum LDH level, no. patients | 47 |
| ECOG performance status, no. patients | |
| 1 | 12 |
| 2 | 29 |
| 3 | 13 |
| 4 | 1 |
| AAIPI risk factors, no. patients | |
| 2 | 20 |
| 3 | 35 |
| Histology, no. patients | |
| DLBCL | 51 |
| Burkitt lymphoma | 1 |
| Post-MTX DLBCL | 1 |
| Follicular grade 3 lymphoma | 1 |
| γδ Hepatosplenic T-cell lymphoma | 1 |